LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Clinical trial NCT01828112 · COMPLETED
Trial details
- NCT number
- NCT01828112
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-28
- Primary completion
- 2016-01-26
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.